Literature DB >> 7042671

Studies on the mechanism of antifungal action of aculeacin A.

H Yamaguchi, T Hiratani, K Iwata, Y Yamamoto.   

Abstract

Aculeacin A was lethal for proliferating cultures of C. albicans. However, there was a paradoxical relationship between the drug concentration and the fungicidal activity; the lethal effect was greatest at levels of 0.08 to 1.25 microgram/ml and increases in the drug concentration above this range reduced its lethal effect. A similar anomalous dose-response patterns were also observed for the inhibitory effect of the drug on several cellular and subcellular biochemical activities. Association of this lethal effect of the drug was the formation of visible cell aggregates and the development of extremely huge forms in treated cultures. Aculeacin A induced osmotically fragile cells and viability of treated cultures was markedly reversed under high osmolarity. Tracer experiments and chemical analysis revealed that synthesis of alkali insoluble glucan was inhibited by the drug to a greater extent than synthesis of mannan and any other species of macromolecules, with resultant formation of alkali-insoluble glucan-deficient cells. Aculeacin A inhibited synthesis of beta-glucan from UDP-glucose catalyzed by cell-free extracts from C. albicans and S. cerevisiae. These data are consistent with the view that one of the principal target of aculeacin A action is on the beta-1,3-glucan synthetase reaction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042671     DOI: 10.7164/antibiotics.35.210

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  20 in total

Review 1.  Yeast killer systems.

Authors:  W Magliani; S Conti; M Gerloni; D Bertolotti; L Polonelli
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Geranylgeranyltransferase I of Candida albicans: null mutants or enzyme inhibitors produce unexpected phenotypes.

Authors:  R Kelly; D Card; E Register; P Mazur; T Kelly; K I Tanaka; J Onishi; J M Williamson; H Fan; T Satoh; M Kurtz
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

3.  Use of Saccharomyces cerevisiae expressing beta-galactosidase to screen for antimycotic agents directed against yeast cell wall biosynthesis and possible application to pathogenic fungi.

Authors:  P G Zaworski; G S Gill
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

Review 4.  Models of cell differentiation in conidial fungi.

Authors:  G T Cole
Journal:  Microbiol Rev       Date:  1986-06

5.  Papulacandin B resistance in budding and fission yeasts: isolation and characterization of a gene involved in (1,3)beta-D-glucan synthesis in Saccharomyces cerevisiae.

Authors:  C Castro; J C Ribas; M H Valdivieso; R Varona; F del Rey; A Duran
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

6.  Nikkomycin Z supersensitivity of an echinocandin-resistant mutant of Saccharomyces cerevisiae.

Authors:  M el-Sherbeini; J A Clemas
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

7.  Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis.

Authors:  M B Kurtz; C Douglas; J Marrinan; K Nollstadt; J Onishi; S Dreikorn; J Milligan; S Mandala; J Thompson; J M Balkovec
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

8.  A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase.

Authors:  C M Douglas; J A Marrinan; W Li; M B Kurtz
Journal:  J Bacteriol       Date:  1994-09       Impact factor: 3.490

9.  Mechanism of action of anticandidal dipeptides containing inhibitors of glucosamine-6-phosphate synthase.

Authors:  S Milewski; R Andruszkiewicz; L Kasprzak; J Mazerski; F Mignini; E Borowski
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

10.  Incorporation of mannoproteins into the walls of aculeacin A-treated yeast cells.

Authors:  E Valentín; E Herrero; R Sentandreu
Journal:  Arch Microbiol       Date:  1986-12       Impact factor: 2.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.